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b Department of Radiology, University Hospital of Strasbourg, Strasbourg, FranceIn their study, Dr. Versluis et al.1 presented the popliteal
arterial peak ﬂow (APF), a measure easily obtained with a
phase-contrast magnetic resonance imaging (MRI)
sequence, as a reliable and reproducible technique able to
discriminate between normal and peripheral arterial
occlusive disease (PAOD) patients. Continuing from their
previous works,2e4 the authors established normative
values for popliteal APF and suggested its use over common
femoral and superﬁcial femoral APF as a functional follow-
up parameter.
The strength of this study relies on the high number of
patients included, 259 with varying degrees of PAOD and 48
patients without PAOD, and successfully imaged with the
same protocol, suggesting that this technique could be used
as a simple yet powerful non-invasive functional parameter.
However, this rather technical work raises some issues,
the most important being the absence of a patient’s clinical
data beyond the simple assessment of a signiﬁcant stenosis;
therefore, making it impossible to correlate the APF with a
patient’s functional status. The authors did not provide any
information about the patients’ clinical data except the
presence or not of PAOD. This point makes it difﬁcult to
conclude on the relation between APF results and func-
tional status. Finally, they included patients with PAOD who
had no stenosis but demonstrated lower APF than non-PAD
patients. Further studies on the relationship with Leriche
and Fontaine classiﬁcation, TASC II classiﬁcation, or Ptc02
seems logical, and would conﬁrm the potential interest of
the technique.
However, such a correlation remains to be demonstrated:
Would it be completely linear? Would it be related to the
amount of vascular calciﬁcations? Would it be inﬂuenced by
current or previous treatments? Would a reliable cut-off
value determining critical ischemia be found?4
The question of a potential cut-off value is indeed critical,
as the APF measured in this study exhibit a large standard
deviation, leading to a signiﬁcant overlap between normal
and PAOD patients. Therefore, if APF values were demon-
strated to be discriminant at the level of a population,
would they still remain pertinent at an individual level? To
better distinguish between various patient populations,DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.04.022
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http://dx.doi.org/10.1016/j.ejvs.2014.05.010additional information could be derived from the phase
contrast images, such as the analysis of the ﬂow waveforms
(systolic rise time, presence of a backﬂow) and the calcu-
lation of APF indexes between proximal and distal measures
(presence of a gradient).
All these issues led us to one ﬁnal question: the clinical
utility of thismeasure.We can technically do it, but shouldwe
actually do it? Magnetic resonance angiography is the most
expansive non-invasive imaging technique, and according to
the current guidelines it is only when an invasive procedure is
planned to improve symptoms that we are supposed to do
imaging investigations and not during standard recom-
mended follow-up. Moreover, MRI time is scarce, so even if
this sequence is only a 1-minute addition, it is not negligible
and has therefore to prove its clinical utility before making it
to the routine practice. MRI lower limb arterial ﬂow mea-
surements have been described since at least 2003,5 yet
additional research is still required before it will able to leave
the academic setting and impose in everyday work.REFERENCES
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